159 related articles for article (PubMed ID: 10022334)
1. Tiered screening and testing strategy for xenoestrogens and antiandrogens.
Gray LE
Toxicol Lett; 1998 Dec; 102-103():677-80. PubMed ID: 10022334
[TBL] [Abstract][Full Text] [Related]
2. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps.
Gray LE; Ostby J; Wilson V; Lambright C; Bobseine K; Hartig P; Hotchkiss A; Wolf C; Furr J; Price M; Parks L; Cooper RL; Stoker TE; Laws SC; Degitz SJ; Jensen KM; Kahl MD; Korte JJ; Makynen EA; Tietge JE; Ankley GT
Toxicology; 2002 Dec; 181-182():371-82. PubMed ID: 12505339
[TBL] [Abstract][Full Text] [Related]
3. Use of the laboratory rat as a model in endocrine disruptor screening and testing.
Gray LE; Wilson V; Noriega N; Lambright C; Furr J; Stoker TE; Laws SC; Goldman J; Cooper RL; Foster PM
ILAR J; 2004; 45(4):425-37. PubMed ID: 15454681
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).
O'Connor JC; Cook JC; Marty MS; Davis LG; Kaplan AM; Carney EW
Crit Rev Toxicol; 2002; 32(6):521-49. PubMed ID: 12487364
[TBL] [Abstract][Full Text] [Related]
5. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
6. Endocrine active agents: implications of adverse and non-adverse changes.
Foster PM; McIntyre BS
Toxicol Pathol; 2002; 30(1):59-65. PubMed ID: 11892727
[TBL] [Abstract][Full Text] [Related]
7. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat.
Wolf C; Lambright C; Mann P; Price M; Cooper RL; Ostby J; Gray LE
Toxicol Ind Health; 1999; 15(1-2):94-118. PubMed ID: 10188194
[TBL] [Abstract][Full Text] [Related]
8. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity.
Naciff JM; Daston GP
Toxicol Pathol; 2004; 32 Suppl 2():59-70. PubMed ID: 15503665
[TBL] [Abstract][Full Text] [Related]
9. Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation.
Sultan C; Balaguer P; Terouanne B; Georget V; Paris F; Jeandel C; Lumbroso S; Nicolas J
Mol Cell Endocrinol; 2001 Jun; 178(1-2):99-105. PubMed ID: 11403899
[TBL] [Abstract][Full Text] [Related]
10. Answering the endocrine test questions.
Schmidt CW
Environ Health Perspect; 1999 Sep; 107(9):A458-60. PubMed ID: 10464085
[TBL] [Abstract][Full Text] [Related]
11. Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues.
McIntyre BS; Barlow NJ; Foster PM
Toxicol Sci; 2001 Aug; 62(2):236-49. PubMed ID: 11452136
[TBL] [Abstract][Full Text] [Related]
12. In vitro models in endocrine disruptor screening.
Charles GD
ILAR J; 2004; 45(4):494-501. PubMed ID: 15454688
[TBL] [Abstract][Full Text] [Related]
13. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee.
Stoker TE; Parks LG; Gray LE; Cooper RL
Crit Rev Toxicol; 2000 Mar; 30(2):197-252. PubMed ID: 10759431
[TBL] [Abstract][Full Text] [Related]
14. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
Pickford DB
Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the EDSTAC female pubertal assay in CD rats using 17beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor.
Marty MS; Crissman JW; Carney EW
Toxicol Sci; 1999 Dec; 52(2):269-77. PubMed ID: 10630580
[TBL] [Abstract][Full Text] [Related]
16. Xenoendocrine disrupters: laboratory studies on male reproductive effects.
Gray LE
Toxicol Lett; 1998 Dec; 102-103():331-5. PubMed ID: 10022274
[TBL] [Abstract][Full Text] [Related]
17. Assessment of in vivo assays for endocrine disruption.
Clode SA
Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):35-43. PubMed ID: 16522518
[TBL] [Abstract][Full Text] [Related]
18. Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat.
Gray LE; Ostby JS; Kelce WR
Toxicol Appl Pharmacol; 1994 Nov; 129(1):46-52. PubMed ID: 7974495
[TBL] [Abstract][Full Text] [Related]
19. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.
Ankley GT; Gray LE
Environ Toxicol Chem; 2013 Apr; 32(5):1084-7. PubMed ID: 23401061
[TBL] [Abstract][Full Text] [Related]
20. Perinatal exposure to mixtures of anti-androgenic chemicals causes proliferative lesions in rat prostate.
Boberg J; Johansson HK; Hadrup N; Dreisig K; Berthelsen L; Almstrup K; Vinggaard AM; Hass U
Prostate; 2015 Feb; 75(2):126-40. PubMed ID: 25327291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
